GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SRCE · Jun 30, 2025

1ST SOURCE CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000034782-25-000080Bank
Sequential deposit growth35thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

0.34% · CORE · VALID

Net-income growth40thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

1.42% · CORE · VALID

Interest-income growth35thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

4.99% · CORE · VALID

Cash and equivalents40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$149.1M · CORE · VALID

Sequential loan growth80thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

3.41% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History60 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.60%
Current
0.34%
Delta
-2.26%
Earnings Growth Decreased
Previous
27.36%
Current
1.42%
Delta
-25.95%
Interest Income Growth Decreased
Previous
5.87%
Current
4.99%
Delta
-0.88%
Liquidity Decreased
Previous
$222.8M
Current
$149.1M
Delta
-$73.7M
Loan Growth Increased
Previous
0.10%
Current
3.41%
Delta
3.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.